For the treatment of glioblastoma, immunotherapy represents a promising, though complex, avenue. Due to the tumour’s highly ...

Aitia, a biotech company pioneering the use of causal AI and Digital Twins in drug discovery and development, is expanding its collaboration with Servier, a global and independent pharmaceutical ...

Researchers Develop Promising Therapy Treatment That Can Kill Glioblastoma Cells in Newly ... and a prevalent type, known as a glioma, has a poor five-year survival rate. In a new study ...

Glioblastoma is the most common and deadliest form of brain cancer. Patients face a bleak prognosis - the average survival after diagnosis is ...

Announced encouraging initial Phase 2 data of BDTX-1535 in patients with recurrent EGFRm NSCLC with a broad spectrum of classical, non-classical, ...

CINCINNATI (WKRC) - Ten years ago, Lauren Hill died from an inoperable brain tumor. Her legacy lives on by raising awareness ...

Agios Pharmaceuticals, Inc. AGIO reported earnings of $16.22 per share for the third quarter of 2024, which missed the Zacks Consensus Estimate of $16.69. In the year-ago quarter, the company had ...

High-grade gliomas, which include the highly aggressive glioblastoma multiforme (GBM), continue to pose treatment challenges. Despite the continued advances in surgical techniques, chemotherapy, ...

The integration of deep learning in hyperspectral imaging enhances brain tumor surgery, improving image quality and precision ...

TME Pharma N.V. (Euronext Growth Paris: ALTME), a clinical-stage biotechnology company focused on developing novel therapies for trea ...

Modifi Biosciences, Inc., has announced that the company has been acquired by Merck, known as MSD outside of the United ...